B Perpoint

2.5k total citations · 1 hit paper
24 papers, 2.0k citations indexed

About

B Perpoint is a scholar working on Pharmacology, Oncology and Internal Medicine. According to data from OpenAlex, B Perpoint has authored 24 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Oncology and 4 papers in Internal Medicine. Recurrent topics in B Perpoint's work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). B Perpoint is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). B Perpoint collaborates with scholars based in France, Belgium and United States. B Perpoint's co-authors include Rachid Zidani, P. Chollet, Françis Lévi, R. Faggiuolo, C. Focan, J Llory, Bruno Coudert, N Le Bail, Sylvie Giacchetti and A. Le Rol and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

B Perpoint

24 papers receiving 1.9k citations

Hit Papers

Phase III Multicenter Randomized Trial of Oxaliplatin Add... 2000 2026 2008 2017 2000 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Perpoint France 11 1.4k 439 397 389 275 24 2.0k
G. Kleber Germany 22 772 0.6× 747 1.7× 1.1k 2.9× 960 2.5× 153 0.6× 59 2.6k
Ponnandai Somasundar United States 19 542 0.4× 225 0.5× 264 0.7× 527 1.4× 73 0.3× 77 1.8k
Catherine M. Pastor Switzerland 27 756 0.5× 651 1.5× 377 0.9× 1.3k 3.3× 38 0.1× 95 2.6k
Finn Ole Larsen Denmark 17 550 0.4× 95 0.2× 237 0.6× 248 0.6× 94 0.3× 49 877
R. Cellerino Italy 25 1.1k 0.8× 75 0.2× 905 2.3× 276 0.7× 300 1.1× 96 2.0k
Jarley Koo Canada 19 1.2k 0.8× 43 0.1× 249 0.6× 428 1.1× 289 1.1× 29 2.1k
Charlotte Costentin France 25 534 0.4× 1.1k 2.5× 219 0.6× 325 0.8× 252 0.9× 71 1.9k
Ming‐Kuen Lai Taiwan 24 252 0.2× 121 0.3× 512 1.3× 512 1.3× 123 0.4× 80 1.9k
Ákos Pap Hungary 15 2.0k 1.4× 70 0.2× 794 2.0× 1.1k 2.9× 47 0.2× 48 2.5k
Roberto Salgado Belgium 13 893 0.6× 62 0.1× 215 0.5× 106 0.3× 61 0.2× 35 1.5k

Countries citing papers authored by B Perpoint

Since Specialization
Citations

This map shows the geographic impact of B Perpoint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Perpoint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Perpoint more than expected).

Fields of papers citing papers by B Perpoint

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Perpoint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Perpoint. The network helps show where B Perpoint may publish in the future.

Co-authorship network of co-authors of B Perpoint

This figure shows the co-authorship network connecting the top 25 collaborators of B Perpoint. A scholar is included among the top collaborators of B Perpoint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Perpoint. B Perpoint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mosnier, Jean‐François, et al.. (1996). An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.. PubMed. 120(7). 654–9. 25 indexed citations
3.
Perpoint, B, et al.. (1994). Dosing Time Optimizes Sustained-Release Ketoprofen Treatment of Osteoarthritis. Chronobiology International. 11(2). 119–125. 10 indexed citations
4.
Lévi, Françis, Rachid Zidani, Jean-Michel Vannetzel, et al.. (1994). Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional Trial. JNCI Journal of the National Cancer Institute. 86(21). 1608–1617. 318 indexed citations
5.
Lévi, Francis, B Perpoint, Carlo Garufi, et al.. (1993). Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. European Journal of Cancer. 29(9). 1280–1284. 162 indexed citations
6.
Perpoint, B, et al.. (1992). Acceptability and Efficacy of Two Associations of Paracetamol with a Central Analgesic (Dextropropoxyphene or Codeine): Comparison in Osteoarthritis. The Journal of Clinical Pharmacology. 32(11). 990–995. 16 indexed citations
7.
Mismetti, Patrick, B Perpoint, S Laporte‐Simitsidis, et al.. (1992). [Chronopharmacology of fractionated heparin (nadroparin) administrated by subcutaneous route at prophylactic doses in healthy volunteers].. PubMed. 47(6). 557–60. 4 indexed citations
8.
Decousus, Hervé, Christian Boissier, B Perpoint, et al.. (1991). Circadian Dynamics of Coagulation and Chronopathology of Cardiovascular and Cerebrovascular Events. Annals of the New York Academy of Sciences. 618(1). 159–165. 13 indexed citations
9.
Decousus, Hervé, B Perpoint, Patrick Mismetti, Michel Ollagnier, & Patrice Queneau. (1990). Good clinical practices in phase I studies. Fundamental and Clinical Pharmacology. 4(S2). 163s–165s. 1 indexed citations
10.
Decousus, Hervé, Silvy Laporte, B Perpoint, et al.. (1990). Comparison in 141 outpatients with osteoarthritis of two combinations of paracetamol with a narcotic analgesic: a controlled clinical trial. European Journal of Pharmacology. 183(3). 1044–1044. 1 indexed citations
11.
Ninet, J., et al.. (1988). [Subclavian and axillary arteritis in Horton's disease and rhizomelic pseudopolyarthritis. 10 cases].. PubMed. 81(1). 89–97. 3 indexed citations
12.
Decousus, H, et al.. (1987). [Biological rhythm and thromboembolic disease. Physiological, epidemiological and pharmacological aspects].. PubMed. 35(6). 985–90. 3 indexed citations
13.
Perpoint, B, et al.. (1986). Hepatitis induced by isoxicam.. PubMed. 33(3). 109–109. 3 indexed citations
14.
Decousus, Hervé, Marine L. Croze, Françis Lévi, et al.. (1985). Circadian changes in anticoagulant effect of heparin infused at a constant rate.. BMJ. 290(6465). 341–344. 128 indexed citations
15.
Queneau, Patrice, et al.. (1985). [Self-medication in rheumatologic consultation. Apropos of a study on 895 patients].. PubMed. 52(2). 79–84. 5 indexed citations
16.
Decousus, H, Marine L. Croze, J. Jaubert, et al.. (1985). [Nycthemeral change in the anticoagulant effect of heparin given at a constant rate by the intravenous route].. PubMed. 300(9). 385–8. 1 indexed citations
17.
Decousus, H, et al.. (1985). Nycthemeral variations of 99Tcm-labelled heparin pharmacokinetic parameters. Nuclear Medicine Communications. 6(10). 633–640. 6 indexed citations
18.
Gabbai, Alberto Alain, et al.. (1982). [Acro-osteolysis in leprosy. Apropos of 19 personal cases].. PubMed. 49(2). 111–9. 5 indexed citations
19.
Perrin‐Fayolle, M, Arjan Bel, R Harf, et al.. (1980). [Asthma and gastro-esophageal reflux. Results of a survey over 150 cases (author's transl)].. PubMed. 36(4). 225–30. 25 indexed citations
20.
Perrin‐Fayolle, M, G Braillon, R Lombard-Platet, et al.. (1980). [Asthma and gastro-esophagal reflux (GER). Results of surgical treatment of reflux in 50 patients (author's transl)].. PubMed. 36(4). 231–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026